Akoya Biosciences, Inc. 3 SEC Filings

Filed On	Filing
03 Sep 2024	Form 3: Bamford Pascal, Chief Clinical Officer Holds 82,758 shares of Common Stock
21 Mar 2023	Form 3: Ek John Frederick, Chief Financial Officer No securities owned
01 Mar 2023	Form 3: Kamocsay Jennifer, General Counsel Holds 0 shares of No securities are beneficially owned.
19 Apr 2022	Form 3: El-Gabry Ehab, Chief Medical Officer Holds 0 shares of No securities are beneficially owned.
24 Jan 2022	Form 3: Moy Marilee, Chief People Officer Holds 0 shares of No securities are beneficially owned.
20 Sep 2021	Form 3: Lai Goldman Myla, Director Holds 0 shares of No securities are beneficially owned.
15 Jun 2021	Form 3: Mendel Scott, Director Holds 0 shares of No securities are beneficially owned.
20 Apr 2021	Form 3: Schnettler Thomas P, Director Holds 0 shares of No securities are beneficially owned.
20 Apr 2021	Form 3: Raffin Thomas A., Director and 6 others Holds 429,184 shares of Common Stock
20 Apr 2021	Form 3: Shepler Robert G, Director Holds 0 shares of No securities are beneficially owned.
20 Apr 2021	Form 3: Ramachandran Niro Ph.D, Chief Business Officer Holds 0 shares of No securities are beneficially owned.
20 Apr 2021	Form 3: Winkler Matthew, Director Holds 781,125 shares of Common Stock
20 Apr 2021	Form 3: Driscoll Joseph, Chief Financial Officer Holds 0 shares of No securities are beneficially owned.
20 Apr 2021	Form 3: Nolan Garry Ph.D., Director Holds 680,084 shares of Common Stock
20 Apr 2021	Form 3: Pla Frederic, Chief Operating Officer Holds 0 shares of No securities are beneficially owned.
20 Apr 2021	Form 3: McKelligon Brian, Director Holds 0 shares of No securities are beneficially owned.

Comments